多吡啶类双核镍配合物的合成、晶体结构及抗癌活性 |
Synthesis, Structure and Anticancer Activity of Binuclear Polypyridine Nickel Complexes |
|
摘要: 合成了2个相似的多吡啶类双核镍配合物[Ni2(L)2Cl2](ClO4)2·3H2O (1)和[Ni2(L)2Cl2](PF6)2(2)(L=N,N-bis (pyridin-2-ylmethyl)-4-(4-((pyridin-2-ylmethyl) amino) benzyl) aniline),通过X射线单晶衍射对其结构进行测定并解析,并利用元素分析、红外光谱对其进行表征。另外,通过噻唑蓝(MTT)比色法检验了2个配合物对HeLa细胞、BGC-823细胞、NCI-H460细胞以及HepG-2细胞的体外毒性作用,结果表明2个配合物均对NCI-H460细胞表现出良好的毒性作用,IC50值分别为(26.0±2.2)μmol·L-1(1)和(31.3±2.7)μmol·L-1(2)。进一步通过Hoechst 33342染色、活性氧水平检测、线粒体膜电位的测定和分析探究了配合物1的抗肿瘤作用机制,结果表明,该配合物可能通过线粒体途径来诱导细胞凋亡从而对癌细胞产生致死作用。 |
关键词: 镍配合物 晶体结构 细胞毒性 线粒体途径 |
基金项目: 山西省重点研发计划项目(No.201703D211001,201903D211006-1,201903D221036)、山西省自然科学基金(No.201701D221157,201701D221158)、山西农业大学省部共建有机旱作农业国家重点实验室自主研发项目(No.202105D121008-3-8)和山西农业大学育种工程项目(No.YZGC096)资助。 |
Abstract: Two new polypyridine dinuclear nickel (Ⅱ) complexes[Ni2(L)2Cl2](ClO4)2·3H2O (1) and[Ni2(L)2Cl2](PF6)2 (2) (L=N,N-bis(pyridin-2-ylmethyl)-4-(4-((pyridin-2-ylmethyl)amino)benzyl)aniline) were synthesized, and their structures were determined by X-ray single crystal diffraction, elemental analysis and infrared spectroscopy. Moreover, the in vitro toxic effects of the two complexes on cancer cells (HeLa, BGC-823, NCI-H460, HepG-2) were tested by thiazole blue (MTT) method, and the results indicate that the two complexes showed good toxicity on NCIH460 cells. IC50=(26.0±2.2) μmol·L-1 (1), (31.3±2.7) μmol·L-1 (2). The cytotoxic mechanism of complex 1 towards NCI-H460 cells was further explored by Hoechst 33342 staining, detection of intracellular reactive oxygen species levels and measurement of mitochondrial membrane potential change. The results demonstrate that complex 1 is likely to induce cell apoptosis through the mitochondrial pathway, thereby causing lethal effects on cancer cells. |
Keywords: nickel complex crystal structure cytotoxicity mitochondrial pathway |
投稿时间:2021-02-02 修订日期:2021-07-16 |
摘要点击次数: 1627 |
全文下载次数: 1033 |
乔佩佩,田玥玮,贺卿,张永坡,高春艳,赵晋忠,杜维俊.多吡啶类双核镍配合物的合成、晶体结构及抗癌活性[J].无机化学学报,2021,37(10):1738-1744. |
查看全文 查看/发表评论 下载PDF阅读器 |
Support information: |
|
|
|